NED Medical Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$8M
- Investors
-
1
NED Medical General Information
Description
Developer of radioembolization medical technology designed to improve treatment outcomes for liver cancer. The company's technology helps transform oncology embolisation from a palliative to a curative treatment, reducing debilitating side effects and toxicities, enabling healthcare professionals to provide better treatment to cancer patients.
Contact Information
Website
www.nedmedical.comCorporate Office
- 2 Fords Crossing
- Norwell, MA 02061
- United States
Corporate Office
- 2 Fords Crossing
- Norwell, MA 02061
- United States
NED Medical Timeline
NED Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 20-Jan-2026 | $8M | Completed | Generating Revenue | ||
| 1. Seed Round | 28-Aug-2023 | Completed | Generating Revenue |
NED Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NED Medical Patents
NED Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026183359-A1 | Radioembolic beads and methods for treatment of tumor cells | Pending | 26-Feb-2025 | ||
| WO-2026097008-A1 | Methods and systems for administration of liquid content | Pending | 01-Nov-2024 | ||
| WO-2026035932-A1 | Beads and methods for making the same | Pending | 09-Aug-2024 | ||
| JP-2026524498-A | Radioembolic beads and methods for the treatment of tumor cells | Pending | 07-Jul-2023 | ||
| EP-4724050-A1 | Radioembolic beads and methods for treatment of tumor cells | Pending | 07-Jul-2023 | A61P35/00 |
NED Medical Signals
NED Medical Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Varian Medical Systems | Corporation | Minority |
NED Medical FAQs
-
When was NED Medical founded?
NED Medical was founded in 2022.
-
Where is NED Medical headquartered?
NED Medical is headquartered in Norwell, MA.
-
What is the size of NED Medical?
NED Medical has 5 total employees.
-
What industry is NED Medical in?
NED Medical’s primary industry is Biotechnology.
-
Is NED Medical a private or public company?
NED Medical is a Private company.
-
What is the current valuation of NED Medical?
The current valuation of NED Medical is .
-
What is NED Medical’s current revenue?
The current revenue for NED Medical is .
-
How much funding has NED Medical raised over time?
NED Medical has raised $8.5M.
-
Who are NED Medical’s investors?
Varian Medical Systems has invested in NED Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process